PDS Biotechnology Corp — Director's Dealing 2023

Jan 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2023-01-05

Reporting Person: CONN GREGORY (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-05	Employee Stock Option (Right to Buy)	$11.61	A	137200	Acquired	2033-01-05	Common Stock (137200)	Direct

Footnotes

F1: This option, representing a right to purchase a total of 137,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.